These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 17050764)
1. HAART adherence strategies for methadone clients who are HIV-positive: a treatment manual for implementing contingency management and medication coaching. Haug NA; Sorensen JL; Gruber VA; Lollo N; Roth G Behav Modif; 2006 Nov; 30(6):752-81. PubMed ID: 17050764 [TBL] [Abstract][Full Text] [Related]
2. Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: the role of methadone maintenance therapy. Palepu A; Tyndall MW; Joy R; Kerr T; Wood E; Press N; Hogg RS; Montaner JS Drug Alcohol Depend; 2006 Sep; 84(2):188-94. PubMed ID: 16542797 [TBL] [Abstract][Full Text] [Related]
3. Voucher reinforcement improves medication adherence in HIV-positive methadone patients: a randomized trial. Sorensen JL; Haug NA; Delucchi KL; Gruber V; Kletter E; Batki SL; Tulsky JP; Barnett P; Hall S Drug Alcohol Depend; 2007 Apr; 88(1):54-63. PubMed ID: 17056206 [TBL] [Abstract][Full Text] [Related]
4. The impact of ongoing illicit drug use on methadone adherence in illicit drug users receiving treatment for HIV in a directly observed therapy program. Raffa JD; Grebely J; Tossonian H; Wong T; Viljoen M; Khara M; Mead A; McLean M; Duncan F; Petkau AJ; DeVlaming S; Conway B Drug Alcohol Depend; 2007 Jul; 89(2-3):306-9. PubMed ID: 17383117 [TBL] [Abstract][Full Text] [Related]
5. The impact of methadone or buprenorphine treatment and ongoing injection on highly active antiretroviral therapy (HAART) adherence: evidence from the MANIF2000 cohort study. Roux P; Carrieri MP; Villes V; Dellamonica P; Poizot-Martin I; Ravaux I; Spire B; Addiction; 2008 Nov; 103(11):1828-36. PubMed ID: 18778390 [TBL] [Abstract][Full Text] [Related]
6. Impact of drug abuse treatment modalities on adherence to ART/HAART among a cohort of HIV seropositive women. Kapadia F; Vlahov D; Wu Y; Cohen MH; Greenblatt RM; Howard AA; Cook JA; Goparaju L; Golub E; Richardson J; Wilson TE Am J Drug Alcohol Abuse; 2008; 34(2):161-70. PubMed ID: 18293232 [TBL] [Abstract][Full Text] [Related]
7. [HIV and drug users: current trends]. Golz JH MMW Fortschr Med; 2005 Apr; 147 Spec No 1():60-2. PubMed ID: 16385879 [TBL] [Abstract][Full Text] [Related]
8. Retention in opioid substitution treatment: a major predictor of long-term virological success for HIV-infected injection drug users receiving antiretroviral treatment. Roux P; Carrieri MP; Cohen J; Ravaux I; Poizot-Martin I; Dellamonica P; Spire B Clin Infect Dis; 2009 Nov; 49(9):1433-40. PubMed ID: 19807275 [TBL] [Abstract][Full Text] [Related]
9. Medication adherence strategies for drug abusers with HIV/AIDS. Sorensen JL; Mascovich A; Wall TL; DePhilippis D; Batki SL; Chesney M AIDS Care; 1998 Jun; 10(3):297-312. PubMed ID: 9828973 [TBL] [Abstract][Full Text] [Related]
10. Poor adherence to HIV monitoring and treatment guidelines for HIV-infected injection drug users. Wood E; Kerr T; Zhang R; Guillemi S; Palepu A; Hogg RS; Montaner JS HIV Med; 2008 Aug; 9(7):503-7. PubMed ID: 18484977 [TBL] [Abstract][Full Text] [Related]
11. Adherence to HAART therapy measured by electronic monitoring in newly diagnosed HIV patients in Botswana. Vriesendorp R; Cohen A; Kristanto P; Vrijens B; Rakesh P; Anand B; Iwebor HU; Stiekema J Eur J Clin Pharmacol; 2007 Dec; 63(12):1115-21. PubMed ID: 17882408 [TBL] [Abstract][Full Text] [Related]
12. Effect of methadone treatment on incarceration rates among injection drug users. Werb D; Kerr T; Marsh D; Li K; Montaner J; Wood E Eur Addict Res; 2008; 14(3):143-9. PubMed ID: 18552490 [TBL] [Abstract][Full Text] [Related]
13. Adherence, stereotyping and unequal HIV treatment for active users of illegal drugs. Ware NC; Wyatt MA; Tugenberg T Soc Sci Med; 2005 Aug; 61(3):565-76. PubMed ID: 15899316 [TBL] [Abstract][Full Text] [Related]
14. An integration of three approaches to addiction and methadone maintenance treatment: the self-medication hypothesis, the disease model and social criticism. Gelkopf M; Levitt S; Bleich A Isr J Psychiatry Relat Sci; 2002; 39(2):140-51. PubMed ID: 12227229 [TBL] [Abstract][Full Text] [Related]
15. Gender differences among HIV-positive methadone maintenance patients enrolled in a medication adherence trial. Haug NA; Sorensen JL; Lollo ND; Gruber VA; Delucchi KL; Hall SM AIDS Care; 2005 Nov; 17(8):1022-9. PubMed ID: 16176898 [TBL] [Abstract][Full Text] [Related]
17. [Study on the adherence and related determinants among HIV-positive clients under methadone maintenance treatment in Dali,Yunnan province from 2005 to 2013]. Jiang H; Cao X; Wang C; Luo W; Li J; Rou K; Zhang B; Fang Y; Li C; Wu Z Zhonghua Liu Xing Bing Xue Za Zhi; 2014 Mar; 35(3):255-8. PubMed ID: 24831621 [TBL] [Abstract][Full Text] [Related]
18. Comparing drug-related hospital morbidity following heroin dependence treatment with methadone maintenance or naltrexone implantation. Ngo HT; Tait RJ; Hulse GK Arch Gen Psychiatry; 2008 Apr; 65(4):457-65. PubMed ID: 18391134 [TBL] [Abstract][Full Text] [Related]
19. Value for money in drug treatment: economic evaluation of prison methadone. Warren E; Viney R; Shearer J; Shanahan M; Wodak A; Dolan K Drug Alcohol Depend; 2006 Sep; 84(2):160-6. PubMed ID: 16487668 [TBL] [Abstract][Full Text] [Related]
20. Impact of methadone on drug use and risky sex in China. Qian HZ; Hao C; Ruan Y; Cassell HM; Chen K; Qin G; Yin L; Schumacher JE; Liang S; Shao Y J Subst Abuse Treat; 2008 Jun; 34(4):391-7. PubMed ID: 17869049 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]